Conditions: Cystic Fibrosis
Intervention Type: Drug
Intervention Name: SB656933
Clinical Trials
The following are clinical trials from the Healia Clinical Trials Information Database that are researching the effect of the "Drug" intervention "SB656933" on "Cystic Fibrosis".
-
An Open Label Dose Ascending, Single Dose Study to Investigate the Pharmacokinetics of SB-656933 in Subjects With Cystic Fibrosis.
NCTID: NCT00605761
-
A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SB-656933 Following 14 Days Repeat Dosing in Healthy Male Smokers.
NCTID: NCT00615576